AsiaNet 86786

BAD HOMBURG, Germany, Nov. 23, 2020, /PRNewswire=KYODO JBN/--

Evidence indicates that omega-3 (w-3) fatty acid containing parenteral

nutrition (PN) improves clinical outcomes compared with standard PN in adult

patients,1 underlining its role in today's hospitals and clinics. To support

continuous health care professional (HCP) education on omega-3 fatty acids in

clinical nutrition, the American Society for Parenteral and Enteral Nutrition

(ASPEN) has partnered with Fresenius Kabi to create the Omega-3 Fatty Acids Key

Expert Interview Series, which includes five interviews addressing important

aspects of omega-3 fatty acids impacting patient care.

The interview series features the following experts and topics: Mette M.

Berger, MD, PhD (Role and Mechanism of Action of omega-3 Fatty Acids); Robert

G. Martindale, MD, PhD (Guideline Recommendations and Use in Surgical

Patients); Martin D. Rosenthal, MD (Use in the Chronic Critical Care Patient);

Lorenzo Pradelli, MD (Cost Effectiveness of omega-3 Fatty Acids); and Manpreet

S Mundi, MD (Omega-3 Fatty Acids in Long-term Intestinal Failure Patients). The

esteemed experts were interviewed by Jay Mirtallo, MS, RPh, BCNSP, FASPEN,

FASHP, who is well published in the area of intravenous lipids.

This short video interview series is available at this link

[https://www.youtube.com/playlist?list=PL-rWCuTTwTKzOuXWmTmUUwUXoS0KQOurk ].

Clinicians can also watch previous ASPEN webinars on omega-3 fatty acids:

- Expert Consensus on Omega-3 Fatty Acids in Parenteral Nutrition: Continuum

of Care – from Hospital to Home Care

[https://aspen.digitellinc.com/aspen/sessions/15181/view ]

- Expert Consensus on Omega-3 Fatty Acids in Parenteral Nutrition: Focus on

Critical Care and Major Surgery

[https://aspen.digitellinc.com/aspen/sessions/15719/view ]

The digital interviews and past webinars are supported by global clinical

nutrition leader, Fresenius Kabi. The supplement of the 2020 Journal of

Parenteral and Enteral Nutrition Lipids in Parenteral Nutrition: Translating

Guidelines into Clinical Practice

[https://onlinelibrary.wiley.com/toc/19412444/2020/44/S1 ] was also developed

on the topic of omega-3 fatty acids with support from Fresenius Kabi.

References

1. Pradelli L, Mayer K, Klek S et al. w-3 Fatty-Acid Enriched Parenteral

Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and

Trial Sequential Analysis. JPEN J Parenter Enteral Nutr. 2019.

About Fresenius Kabi

Fresenius Kabi is a global healthcare company that specializes in lifesaving

medicines and technologies for infusion, transfusion and clinical nutrition.

The company's products and services are used to help care for critically and

chronically ill patients. Fresenius Kabi's product portfolio comprises a

comprehensive range of I.V. generic drugs, infusion therapies and clinical

nutrition products as well as the medical devices for administering these

products. Within transfusion technologies, Fresenius Kabi offers products for

collection and processing of blood components and for therapeutic treatment of

patient blood by apheresis systems. In the field of biosimilars, Fresenius Kabi

develops products with a focus on oncology and autoimmune diseases.

With its corporate philosophy of "caring for life", the company is committed to

putting essential medicines and technologies in the hands of people who help

patients and finding the best answers to the challenges they face.

For more information, please visit: www.fresenius-kabi.com.

About ASPEN

The American Society for Parenteral and Enteral Nutrition (ASPEN) is dedicated

to improving patient care by advancing the science and practice of nutrition

support therapy and metabolism. Founded in 1976, ASPEN is an interdisciplinary

organization whose members are involved in the provision of clinical nutrition

therapies, including parenteral and enteral nutrition. With more than 6,500

members from around the world, ASPEN is a community of dietitians, nurses,

nurse practitioners, pharmacists, physicians, scientists, students and other

health professionals from every facet of nutrition support clinical practice,

research and education.

For more information about ASPEN, please visit: www.nutritioncare.org.

For press inquiries, please contact:

Nina Espiritu

Edelman GmbH

Am Sandtorkai 50, 20457 Hamburg, Germany

T: +49-(0)69-509546339

nina.espiritu@edelman.com  

SOURCE: Fresenius Kabi Deutschland GmbH